Literature DB >> 15610926

Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice.

M Carmen Carrasco1, Paloma Vicens, Jose Vidal, Rosa Redolat.   

Abstract

Bupropion attenuates some symptoms of nicotine abstinence, although its effects on anxiety are unclear. The present study investigates acute effects of bupropion (5, 10, 20 and 40 mg/kg) on anxiety as expressed in the elevated plus-maze test in male NMRI mice. Given the influence of locomotion in this test, effects of bupropion were also evaluated in an actimeter. Spontaneous motor activity remained significantly increased in mice treated with 10, 20 and 40 mg/kg of bupropion during the 60 min recorded. Results from the elevated plus-maze showed that 20 mg/kg increased total arm entries and 40 mg/kg increased total and open arm entries. Although the increase in the number of visits to the open arms suggests an anxiolytic-like effect, if the actions of this drug on locomotion are taking into account, one may conclude that the increase in open arm entries observed with the highest doses is a motor effect rather than anxiolysis per se. In addition, ethological measures failed to detect a clear anxiolytic profile since neither a significant decrease in total stretched attend postures nor a reduction in the percentage of protected forms of head dipping or stretched attend postures were observed at any dose tested. These results suggest that the elevated plus-maze is sensitive to the motor actions of bupropion and that this should be taken into account in the evaluation of the "emotional" effects of this drug.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15610926     DOI: 10.1016/j.pnpbp.2004.06.005

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

Review 1.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

2.  Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash.

Authors:  F L Wright; R J Rodgers
Journal:  Psychopharmacology (Berl)       Date:  2013-03-01       Impact factor: 4.530

3.  Isobolographic analysis of the antidepressant interaction in two-drug combinations of citalopram, bupropion, and scopolamine in mice.

Authors:  Mohammad-Hossein Mohammadi-Mahdiabadi-Hasani; Mohaddeseh Ebrahimi-Ghiri; Fatemeh Khakpai; Mohammad-Reza Zarrindast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-04-19       Impact factor: 3.000

4.  Cluster analysis profiling of behaviors in zebrafish larvae treated with antidepressants and pesticides.

Authors:  Holly Richendrfer; Robbert Creton
Journal:  Neurotoxicol Teratol       Date:  2017-10-31       Impact factor: 3.763

5.  Novel drug-regulated transcriptional networks in brain reveal pharmacological properties of psychotropic drugs.

Authors:  Michal Korostynski; Marcin Piechota; Jaroslaw Dzbek; Wiktor Mlynarski; Klaudia Szklarczyk; Barbara Ziolkowska; Ryszard Przewlocki
Journal:  BMC Genomics       Date:  2013-09-08       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.